On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
WednesdayJul 17, 2024 3:10 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Noteworthy Findings from Interim Results of Ongoing Diabetes Animal Study

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced the receipt of interim results from the first four weeks of dosing in its ongoing diabetes animal study WEIGHT-A24-1. The company noted that the results have already produced several noteworthy findings. According to the announcement, unlimited food and water have been provided to the animals for the entire duration of the study. During the initial acclimation phase, which spanned 34 days before the beginning of dosing, the animals gained 10.9% body weight on average. During the subsequent 28 days of DehydraTECH-processed drug therapy dosing, all test…

Continue Reading

TuesdayJul 16, 2024 1:31 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Makes Management Announcement, Plans for Strategic Growth

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug-delivery platforms, is preparing for growth by executing a strategic growth plan. A key element of the plan includes expanding the company’s management team to enable efficient handling of a greater workload of projects and initiatives. With that in mind, the company has named Nelson Cabatuan as consulting chief strategic financial advisor; Cabatuan is currently serving as Lexaria CFO. In his new role, Cabatuan will leverage his skills in corporate finance and strategic industry relationships to focus on strategic opportunities. In addition, Lexaria is working on other research and development projects…

Continue Reading

ThursdayJul 11, 2024 10:34 am

CannabisNewsBreaks – Golden Triangle Ventures Inc. (GTVH) Hails ABI Create’s ‘Stellar Reputation and Proven Track Record’ Amid Plans to Make Destino Ranch a World-Class Destination

Golden Triangle Ventures (OTC: GTVH), a multifaceted consulting company, today provided an update on ABI Create’s legacy and vision for the future. ABI Create is a division within Lavish Entertainment, a wholly owned subsidiary of Golden Triangle Ventures. Founded in 2015 by Marco Antonio Moreno, ABI Create has earned a reputation for delivering top-quality productions at major events across the United States. ABI Create offers an all-in-one approach, making it a preferred partner for large-scale productions with a comprehensive suite of services, including event organization, management, production, logistics, site planning and permit consulting, construction, contracting, custom design, and fabrication. According…

Continue Reading

TuesdayJul 09, 2024 3:16 pm

CannabisNewsBreaks – CannaCon Event to Propel Networking, Knowledge Exchange in Fast-Growing Sector

CannaCon, a premier conference company that produces state-of-the-art B2B events for cannabis businesses, marijuana entrepreneurs, investors, and community partners to showcase industry products, people, innovations, and technology, today announced plans to host the 5th CannaCon Midwest St.Paul on Aug. 16-17, 2024. The event, designed to drive growth of the cannabis industry in both the Midwest and nationally while creating lasting value for the sector through high-powered networking and knowledge exchange, is slated to take place at the iconic Saint Paul River Center in St. Paul, Minnesota. Like-minded entrepreneurs and industry professionals will convene for the event with a mission to…

Continue Reading

TuesdayJul 09, 2024 2:29 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Completes Dosing in Second GLP-1 Human Pilot Study

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced that human pilot study #2, GLP-1-H24-2, has now completed all dosing. The final DehydraTECH study arm used a Rybelsus(R) composition processed with DehydraTECH that is compliant with the FDA’s Inactive Ingredient Database (“FDA IID”), delivered within an in-mouth dissolvable tablet. According to the announcement, this will be the first study designed to investigate whether DehydraTECH-enhanced semaglutide can absorb at any level systemically through the sublingual/buccal tissues of the mouth and throat with fewer side effects than from swallowed administration, and with some effective drug delivery into…

Continue Reading

WednesdayJun 26, 2024 1:15 pm

CannabisNewsBreaks – GRN Holding Corp. (GRNF) Rebranding with Marijuana Icon Leading at Helm

GRN Holding (OTC: GRNF), a publicly quoted company focused on the global distribution and sale of marijuana in jurisdictions where it is legal, is in the process of a strategic rebranding initiative; the company is rebranding to Marijuana Inc. According to the announcement, the rebranding strategy represents “a new era of growth and innovation in the global cannabis industry.” This transformation is being led by Donald Steinberg, who has been involved in the marijuana space for more than 50 years and has been called the “Henry Ford of the marijuana industry.” Steinberg’s contributions to the world of marijuana have been well…

Continue Reading

ThursdayJun 20, 2024 3:52 pm

CannabisNewsBreaks – Astrotech Corporation’s (NASDAQ: ASTC) TRACER 1000(TM) Receives ‘Approved’ Status on Air Cargo Security Technology List

Astrotech (NASDAQ: ASTC) and its wholly owned subsidiary, 1st Detect Corporation, today announced that the U.S. Transportation Security Administration (“TSA”) has approved the TRACER 1000(TM) for the Air Cargo Security Technology List (“ACSTL”) following thorough assessment by the TSA QG2 Technical Review Panel (“TRP”). Following the approval, regulated parties in the U.S., such as the air cargo market, which are required to use the ACSTL, can now purchase the TRACER 1000. This approval, the announcement noted, advances the TRACER 1000 to Stage II testing. Once the field testing is successfully completed, the TRACER 1000 will move to the “Qualified” section…

Continue Reading

ThursdayJun 20, 2024 12:21 pm

CannabisNewsBreaks – Golden Triangle Ventures Inc. (GTVH) Announces Significant Progress on Destino Ranch Project

Golden Triangle Ventures (OTC: GTVH) (“GTV”) today provided an update on its premier project, Destino Ranch, which is being developed by the company’s entertainment division through its wholly owned subsidiary, Lavish Entertainment. Destino Ranch is a bold project led by Lavish, designed to provide a unique combination of world-class entertainment, opulent accommodations and immersive experiences. Lavish has made significant progress in developing Destino Ranch over the past six months, including a massive overhaul of the irrigation system and extensive cleanup efforts including the repair of perimeter fencing, reinstallation of gates, and opening of roadways around the project. Tree care has…

Continue Reading

WednesdayJun 12, 2024 3:25 pm

CannabisNewsBreaks – Software Effective Solutions Corp. (SFWJ) Collaborates to Begin Exporting CBD Buds to Switzerland

Software Effective Solutions (OTC: SFWJ) (d/b/a MedCana), a holding company focused in the cannabis and agricultural technology sectors, has announced a new strategic partnership with one of its subsidiaries with a prominent local Colombian company to begin the export of its first crop of CBD buds to Switzerland within the next six months. The collaboration marks a major milestone in MedCana’s expansion into the European market and its commitment to delivering high-quality CBD products internationally. “We are thrilled to partner with such a reputable local company in Colombia,” said Gabriel Diaz, CEO of MedCana. “This partnership not only strengthens our…

Continue Reading

TuesdayJun 11, 2024 1:14 pm

CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Participation at Upcoming Emerging Growth Conference

InMed Pharmaceuticals (NASDAQ: INM), a clinical-stage pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates, will be featured in this week’s Emerging Growth Conference. The conference is slated for June 12–13, 2024. According to the announcement, InMed Pharmaceuticals CEO Eric A. Adams will be presenting at the two-day event. During his presentation, Adams will provide a corporate overview of the company; the presentation will also include a Q&A session. Adams’ presentation is scheduled to begin at 1:45 p.m. EDT on June 13. An archived replay of the presentation will be available on the InMed Pharmaceuticals website.…

Continue Reading

Official NewsWire Relationships

Alternative Products Expo Benzinga Cannabis Capital Conference Cannabis Business Summit & Expo 2019 Cannabis Drinks Expo Cannabis World Congress & Business Exposition Cannexpo Marigold PR MjMicro Conference New England Cannabis Network O'Cannabiz Conference & Expo Tether BudTender Tether BudTender Appreciation Week

CannabisNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 303.498.7722